Fig 3. Change in FIB-4 and NFS category from baseline until 24 months follow-up.

Proportion of randomized patients that either improved (changed to a lower category), worsened (changed to a higher category) or did not change in category. Proportion of change is significantly different between treatment and placebo for FIB-4 (A) and NFS (B). FIB-4: Both improvement and worsening P<0.001, NFS: Improvement P<0.004, worsening P = 0.024.